192 related articles for article (PubMed ID: 34229299)
21. Identification of Potential Biomarkers Associated with Prognosis in Gastric Cancer via Bioinformatics Analysis.
Li D; Yin Y; He M; Wang J
Med Sci Monit; 2021 Feb; 27():e929104. PubMed ID: 33582701
[TBL] [Abstract][Full Text] [Related]
22. FN1, SPARC, and SERPINE1 are highly expressed and significantly related to a poor prognosis of gastric adenocarcinoma revealed by microarray and bioinformatics.
Li L; Zhu Z; Zhao Y; Zhang Q; Wu X; Miao B; Cao J; Fei S
Sci Rep; 2019 May; 9(1):7827. PubMed ID: 31127138
[TBL] [Abstract][Full Text] [Related]
23. Identification of differentially expressed genes and functional annotations associated with metastases of the uveal melanoma.
Xu Y; Han W; Xu WH; Wang Y; Yang XL; Nie HL; Yao J; Shen GL; Zhang XF
J Cell Biochem; 2019 Nov; 120(11):19202-19214. PubMed ID: 31270856
[TBL] [Abstract][Full Text] [Related]
24. Increased infiltration of CCR4-positive regulatory T cells in prostate cancer tissue is associated with a poor prognosis.
Watanabe M; Kanao K; Suzuki S; Muramatsu H; Morinaga S; Kajikawa K; Kobayashi I; Nishikawa G; Kato Y; Zennami K; Nakamura K; Tsuzuki T; Yoshikawa K; Ueda R; Sumitomo M
Prostate; 2019 Oct; 79(14):1658-1665. PubMed ID: 31390096
[TBL] [Abstract][Full Text] [Related]
25. Microarray analysis of the expression profile of immune-related gene in rapid recurrence early-stage lung adenocarcinoma.
Liu J; Yang X; Zhang L; Yang B; Rao W; Li M; Dai N; Yang Y; Qian C; Zhang L; Xiao H; Wang D
J Cancer Res Clin Oncol; 2020 Sep; 146(9):2299-2310. PubMed ID: 32556504
[TBL] [Abstract][Full Text] [Related]
26. The Identification of Key Gene Expression Signature in Prostate Cancer.
Huang Y; Cao Q; Song Z; Ruan H; Wang K; Chen K; Zhang X
Crit Rev Eukaryot Gene Expr; 2020; 30(2):153-168. PubMed ID: 32558494
[TBL] [Abstract][Full Text] [Related]
27. The Gene Expression Landscape of Prostate Cancer BM Reveals Close Interaction with the Bone Microenvironment.
Saraji A; Duan K; Watermann C; Hempel K; Roesch MC; Krupar R; Stegmann-Frehse J; Jonigk D; Kuehnel MP; Klapper W; Merseburger AS; Kirfel J; Perner S; Offermann A; Sailer V
Int J Mol Sci; 2022 Oct; 23(21):. PubMed ID: 36361816
[TBL] [Abstract][Full Text] [Related]
28. Up-regulation of proliferative and migratory genes in regulatory T cells from patients with metastatic castration-resistant prostate cancer.
Huen NY; Pang AL; Tucker JA; Lee TL; Vergati M; Jochems C; Intrivici C; Cereda V; Chan WY; Rennert OM; Madan RA; Gulley JL; Schlom J; Tsang KY
Int J Cancer; 2013 Jul; 133(2):373-82. PubMed ID: 23319273
[TBL] [Abstract][Full Text] [Related]
29. Immune-related genes in tumor-specific CD4
Yang X; Wu W; Pan Y; Zhou Q; Xu J; Han S
BMC Cancer; 2020 Jun; 20(1):585. PubMed ID: 32571262
[TBL] [Abstract][Full Text] [Related]
30. Identification for Exploring Underlying Pathogenesis and Therapy Strategy of Oral Squamous Cell Carcinoma by Bioinformatics Analysis.
Xu Z; Jiang P; He S
Med Sci Monit; 2019 Dec; 25():9216-9226. PubMed ID: 31794546
[TBL] [Abstract][Full Text] [Related]
31. Regulatory network of differentially expressed genes in metastatic osteosarcoma.
Yao P; Wang ZB; Ding YY; Ma JM; Hong T; Pan SN; Zhang J
Mol Med Rep; 2015 Mar; 11(3):2104-10. PubMed ID: 25434727
[TBL] [Abstract][Full Text] [Related]
32. Identification of Key Genes and Circular RNAs in Human Gastric Cancer.
Hao S; Lv J; Yang Q; Wang A; Li Z; Guo Y; Zhang G
Med Sci Monit; 2019 Apr; 25():2488-2504. PubMed ID: 30948703
[TBL] [Abstract][Full Text] [Related]
33. POLE2 Serves as a Prognostic Biomarker and Is Associated with Immune Infiltration in Squamous Cell Lung Cancer.
Wu Z; Wang YM; Dai Y; Chen LA
Med Sci Monit; 2020 Apr; 26():e921430. PubMed ID: 32304567
[TBL] [Abstract][Full Text] [Related]
34. Estimation of Hub Genes and Infiltrating Immune Cells in Non-Smoking Females with Lung Adenocarcinoma by Integrated Bioinformatic Analysis.
Li J; Wang B; Li X; Zhu Y
Med Sci Monit; 2020 Jul; 26():e922680. PubMed ID: 32669531
[TBL] [Abstract][Full Text] [Related]
35. Identification of Prognostic Biomarker Signatures and Candidate Drugs in Colorectal Cancer: Insights from Systems Biology Analysis.
Rahman MR; Islam T; Gov E; Turanli B; Gulfidan G; Shahjaman M; Banu NA; Mollah MNH; Arga KY; Moni MA
Medicina (Kaunas); 2019 Jan; 55(1):. PubMed ID: 30658502
[TBL] [Abstract][Full Text] [Related]
36. Construction of Bone Metastasis-Specific Regulation Network Based on Prognostic Stemness-Related Signatures in Prostate Cancer.
Zhuang J; Li M; Zhang X; Xian S; Zhang J; Yin H; Liu Y; Fan M; Li Z; Zhu X; Lin R; Wang S; Zhou Z; Wei C; Yan P; Meng T; Huang R; Huang Z
Dis Markers; 2022; 2022():8495923. PubMed ID: 35392496
[TBL] [Abstract][Full Text] [Related]
37. Characterizing the molecular features of ERG-positive tumors in primary and castration resistant prostate cancer.
Roudier MP; Winters BR; Coleman I; Lam HM; Zhang X; Coleman R; Chéry L; True LD; Higano CS; Montgomery B; Lange PH; Snyder LA; Srivastava S; Corey E; Vessella RL; Nelson PS; Üren A; Morrissey C
Prostate; 2016 Jun; 76(9):810-22. PubMed ID: 26990456
[TBL] [Abstract][Full Text] [Related]
38. A novel risk score model based on eight genes and a nomogram for predicting overall survival of patients with osteosarcoma.
Wu G; Zhang M
BMC Cancer; 2020 May; 20(1):456. PubMed ID: 32448271
[TBL] [Abstract][Full Text] [Related]
39. Screening and validating the core biomarkers in patients with pancreatic ductal adenocarcinoma.
Li Y; Zhu YY; Dai GP; Wu DJ; Gao ZZ; Zhang L; Fan YH
Math Biosci Eng; 2019 Nov; 17(1):910-927. PubMed ID: 31731384
[TBL] [Abstract][Full Text] [Related]
40. In silico identification of key genes and signaling pathways targeted by a panel of signature microRNAs in prostate cancer.
Baruah MM; Sharma N
Med Oncol; 2019 Apr; 36(5):43. PubMed ID: 30937635
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
